Medical Device News Magazine

Wenzel Spine Announces the Launch of the S-LIF Procedure: Prioritizing Surgical Minimalism for Outpatient Spine Fusion

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today announced the launch of the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion using the VariLift®-LX device, the only stand-alone expandable posterior lumbar interbody fusion device that is FDA-cleared for 1 or 2 level fusion.

In addition, Wenzel Spine recently held its first S-LIF Training Lab in Austin, Texas in August to give surgeons the opportunity to gain hands-on experience with this practice-differentiating procedure and explore new ways they can prioritize surgical minimalism for appropriate patients in their practice.

William Wilson, newly appointed CEO of Wenzel Spine, noted, “Surgeons came to the lab with the question, ‘If I’m doing a least-invasive surgery and not incorporating screws and rods, how can I have confidence knowing that this technology will lead to strong, stable fusion for my patients?’ It was validating to watch them leave feeling excited, saying, ‘I can’t wait to start using this more and more in my practice.’”

Participating in the training was Ahmer Ghori, M.D., an orthopedic surgeon in Fort Wayne, Indiana, who has done 50+ “Awake Fusion” procedures with Wenzel’s VariLift. He stated, “Increasingly, surgeons are asking, ‘What is the least invasive spine surgery that I can do for this patient?’ The VariLift device has allowed me to operate on some patients on an outpatient basis, usually using a local spinal anesthetic; and with the correct anesthesia plan, they have reasonable pain control to where they can go home and return to their lives sooner than if they had undergone a much bigger operation.”

But oftentimes, surgeons think that using a stand-alone device might lead to subsidence, or question whether the simplified construct will eventually fail.

Not so, says Michael Weiss, M.D., an orthopedic surgeon in Boca Raton, Florida. “When you insert the device, screw it into place, expand it, and hear the mechanism pulling those bones apart, you see and feel the results. They don’t subside. They give you excellent bone graft abilities. And after you’ve done a few of these, you then get the confidence that, ‘I don’t need all that posterior fixation,’ because the anterior column, when that’s solid, it’s solid and your spine is stable. So, if you are worried that this is not enough, you can allay those fears, because it is.”

Another Surgeon Faculty member, Adam Kremer, M.D., a neurosurgeon in Bay City, Michigan, agrees saying, “Using this device to restore height and alignment and stabilize the weak joint, I feel very strongly that I’m fixing the root cause, and having an outpatient lumbar fusion surgery option really gives patients hope.”

As spinal fusion procedures continue to migrate to the ASC and outpatient environments, the S-LIF Procedure is positioned as an ideal complement for the right patient. And with more research and validation emerging around the use of local spinal anesthetic for fusion procedures, a stand-alone option with a single implant and a single incision takes the fear out of the word “fusion” for patients.

Alex West, M.D., a neurosurgeon in Houston, Texas, added, “People hear the word ‘fusion’ and they get very nervous. With VariLift, my patients are going home in two hours in many cases. One patient called me the following morning and said, ‘Something is wrong because I don’t have any pain.’ Being able to use a least-invasive device with a zero-profile construct that expands in situ makes a world of difference to patient and surgeon alike.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”